• Mauro Picardo
  • Alain Taïeb

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Defining the Disease

    1. Front Matter
      Pages 1-1
    2. Yvon Gauthier, Laila Benzekri
      Pages 3-10
    3. Alain Taïeb, Mauro Picardo
      Pages 11-23
    4. Carlo Cota, Daniela Kovacs
      Pages 25-37
    5. Alain Taïeb, Mauro Picardo
      Pages 39-39
    6. Thierry Passeron, Jean-Paul Ortonne, Prasad Kumarasinghe, Alain Taïeb
      Pages 41-51
    7. Seung-Kyung Hann, Hsin-Su Yu, Cheng-Che Eric Lan, Ching-Shuang Wu, Yvon Gauthier, Laïla Benzekri et al.
      Pages 53-71
    8. Alain Taïeb
      Pages 73-80
    9. Alain Taïeb, Khaled Ezzedine, Julien Seneschal, Ratnam Attili
      Pages 81-91
    10. Anuradha Bishnoi, Davinder Parsad
      Pages 93-102
    11. Tag S. Anbar, Rehab A. Hegazy, Suzan Shalaby
      Pages 103-113
    12. Nanja van Geel, Reinhart Speeckaert
      Pages 115-120
    13. Steven Thng, Sai Yee Chuah, Emily Yiping Gan
      Pages 141-151
    14. Onyeka Obioha, Candrice Heath, Pearl E. Grimes
      Pages 153-161
    15. Alain Taïeb, Mauro Picardo
      Pages 169-176
    16. Anuradha Bishnoi, Davinder Parsad
      Pages 177-180
    17. Alain Taïeb, Mauro Picardo
      Pages 181-185
  3. Understanding the Disease

    1. Front Matter
      Pages 187-187
    2. Mauro Picardo
      Pages 189-192
    3. Gisela F. Erf, I. Caroline Le Poole
      Pages 205-223
    4. Maria Lucia Dell’Anna, Muriel Cario-André
      Pages 225-236
    5. Richard A. Spritz
      Pages 237-251
    6. Li Zhou, Henry W. Lim, Qing-Sheng Mi
      Pages 253-264
    7. Véronique Delmas, Lionel Larue
      Pages 265-275
    8. Mauro Picardo, Maria Lucia Dell’Anna
      Pages 277-283
    9. Kirsten C. Webb, Steven W. Henning, I. Caroline Le Poole
      Pages 285-301
    10. Markus Böhm, Katia Boniface, Silvia Moretti
      Pages 303-312
    11. Mari Dezawa, Kenichiro Tsuchiyama, Kenshi Yamazaki, Setsuya Aiba
      Pages 313-328
    12. Maria Lucia Dell’Anna, Mauro Picardo
      Pages 329-332
    13. Nanja van Geel, Carole Van Haverbeke, Reinhart Speeckaert
      Pages 333-336
    14. Mauro Picardo, Alain Taïeb
      Pages 337-342
  4. Treating the Disease

    1. Front Matter
      Pages 343-343
    2. Alain Taïeb, Mauro Picardo
      Pages 345-351
    3. Alain Taïeb
      Pages 353-379
    4. Boon Kee Goh
      Pages 381-398
    5. Abdulrahman Aljamal, Mohammed Aljamal, Sanjeev Mulekar, Aleissa Ahmed
      Pages 399-409
    6. Alida DePase, Thomas Jouary
      Pages 421-427
    7. Alessia Pacifico, Giovanni Leone, Mauro Picardo
      Pages 429-435
    8. Panagiota Kostopoulou, Alain Taïeb
      Pages 451-454
    9. Jean-Marie Meurant
      Pages 455-462
    10. Tag S. Anbar, Rehab A. Hegazy, Amira A. Eid
      Pages 469-479
    11. Alain Taïeb, Mauro Picardo
      Pages 481-483

About this book


Since the first edition of this book was published, new knowledge has been gained on Vitiligo. This widely revised and updated second edition, written by worldwide experts in the field, fully reflects this progress. The apparently, simple and poorly symptomatic presentation of the disease has been a strong disadvantage to its study, as compared to other common chronic skin disorders such as psoriasis and atopic dermatitis. A good skin-based angle of attack is also lacking because generalized Vitiligo is clearly epitomizing the view of skin diseases as simple targets of a systemic unknown dysregulation (diathesis). This view has mostly restricted Vitiligo to the manifestation of an auto-immune diathesis and skin events, which are easily detected using skin biospies in most other situations, have not been precisely recorded, with the argument that a clinical diagnosis was sufficient for the management of the patient with Vitiligo. This richly illustrated  second edition reflects the constant international effort to share the information gathered about this disorder at the clinical, pathophysiological and therapeutic levels. Its aim still being to bridge current knowledge at the clinical and investigative level, to point to the many unsolved issues, and to delineate future priorities for research.


Combined therapies Immune activation Melanocyte degeneration Melanocyte transplantation Phototherapy

Editors and affiliations

  • Mauro Picardo
    • 1
  • Alain Taïeb
    • 2
  1. 1.Cutaneous Physiopathology & CIRMSan Gallicano Dermatological InstituteRomeItaly
  2. 2.Hôpital Saint André, Service de Dermatologie Adulte et Pédiatrique, INSERM U 1035, Université de BordeauxBordeauxFrance

Bibliographic information

Industry Sectors
Health & Hospitals
Internal Medicine & Dermatology
Consumer Packaged Goods